/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
-0.21%
Natural Gas
+2.22%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.11%
VIX
N/A
Economic Calendar
EUR/USD
-0.21%
Natural Gas
+2.22%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.11%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Key PCE Inflation Gauge Rose 2.8% Annually in February as Expected
about 3 hours ago
Will the PCE Report Derail the Fed’s Anticipated Rate Cut Plans?
about 3 hours ago
The Market News Today: Upcoming PCE Report to Influence Fed’s Rate Decisions
about 5 hours ago
US GDP for Previous Quarter Adjusted Upward to a Robust Annual 3.4%
1 day ago
The Market News Today: US GDP Forecast at 3.2%, Eyes on Fed and Market Response
1 day ago
German Retail Sales Tumble 1.9% in February Driving ECB Rate Cut Bets
1 day ago
Silver Weekly Price Forecast – Silver Continues to Look Bullish
7 minutes ago
Natural Gas Price Forecast – Natural Gas Continues to See Sideways Action
18 minutes ago
USD/JPY Forecast – US Dollar Continues to See Pressure Build
22 minutes ago
Crude Oil Price Forecast – Crude Likely to Continue Higher
30 minutes ago
AUD/USD Forecast – Aussie Continues to Do Nothing
36 minutes ago
Natural Gas News: Weather Change Fuels Bear Market Short-Covering Rally
37 minutes ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
MRK
profile
Merck & Co Inc
Follow
MRK
(
NYSE
)
Closed
131.91
+0.16 (+0.12%)
in
:
usd
•
As of: Mar 28, 2024 15:59
UTC -4
After Market
:
131.94
+0.03 (+0.02%)
Open
132.00
High
132.42
Low
131.09
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Dividends
About
Merck & Co Inc
CEO
Robert M. Davis
Headquarters
126 east lincoln avenue
rahway, nj 07065, united states
Auditor
PricewaterhouseCoopers LLP
Employees
72,000
Share Holders
90,400
Website
www.merck.com
Industry
pharmaceuticals major
Sector
health technology
Company Overview
Merck & Co. boasts more than six blockbuster drugs in its portfolio with PD-L1 inhibitor, Keytruda, approved for several types of cancer. Keytruda has played an instrumental role in driving Merck's steady revenue growth in the past few years. Well-known products in Merck's portfolio include Keytruda, Simponi , Januvia and Janumet, Bridion, Isentress, ProQuad, Gardasil, Pneumovax 23, RotaTeq and Belsomra. Merck made its biggest acquisition of Schering-Plough and sold off its Consumer Care business to Bayer. Other key acquisitions include Idenix Pharmaceuticals, Cubist Pharmaceuticals, Rigontec, ArQule and Acceleron Pharma. IMerck spun off products from its Women's Health unit, legacy drugs and biosimilar products into a new publicly traded company called Organon & Co.
Merck & Co Inc
Statistics
Valuation Measures
Market Capitalization
2
334.08B
Enterprise Value
362.29B
Enterprise Value/EBITDA
(ttm)
53.08
Price to Earnings Ratio
(ttm)
87.83
Price to Book
(mrq)
8.87
Price to Sales
(ttm)
5.55
Price to Cash
(ytd)
43.31
Profitability
Gross Margin
(ttm)
73.17%
Operating Margin
(ttm)
6.38%
Profit Margin
(ttm)
0.27%
Return on Equity
(ttm)
9.33%
Return on Invested Capital
(ttm)
0.16%
Return on Assets
(ttm)
3.61%
Income Statement
Revenue
(ttm)
60.12B
Revenue Per Share
(ttm)
23.74
Gross Profit
(ttm)
43.99B
EBITDA
(ttm)
3
6.83B
Net Income Avi to Common
(ttm)
365.00M
Diluted EPS
(ttm)
0.14
Share Statistics
Beta (5Y Monthly)
0.37
52-Week Change
29.16%
S&P500 52-Week Change
30.45%
S&P500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding
1
2.53B
Dividend Yield
2.34%
Float
4
2.53B
%
Held by Insiders
0.20%
%
Held by Institutions
76.07%
Balance Sheet
Total Cash
(mrq)
7.09B
Total Cash Per Share
(mrq)
2.80
Total Debt
(mrq)
35.05B
Total Debt/Equity
(mrq)
93.14%
Current Ratio
(mrq)
1.25%
Quick Ratio
(mrq)
1.00%
Book Value Per Share
(mrq)
14.87
Cash Flow
Operating Cash Flow Per Share
(ytd)
5.11
Free Cash Flow
(ytd)
9.14B
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker